The need for new device therapies in HFrEF

1,964 views | 21 Jun 2022
CVRx | Barostim

56 videos

Barostim™ Baroreflex Activation Therapy is a new option for patients with heart failure that utilizes the carotid baroreflex to target autonomic imbalance in the cardiovascular system.

Speakers
Initials JS of Jagmeet Singh JS

Jagmeet Singh is a professor of medicine at Harvard Medical School, Massachusetts General Hospital,Boston, MA, USA.

Start a conversation